Higher Circulating Sphingosine 1-Phosphate Levels Are Associated with Lower Bone Mineral Density and Higher Bone Resorption Marker in Humans
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
CONTEXT: Several in vivo and in vitro studies suggest that sphingosine-1-phosphate (S1P) is known to act as a coupling factor, to stimulate osteoclastogenesis, to control the migration of osteoclast precursors between the blood and bone, and to stimulate the proliferation, migration, and survival of osteoblasts. OBJECTIVE: Using the determination of circulating S1P levels, we investigated which kinds of processes may be primarily affected by S1P in humans. DESIGN AND SETTING: This was a cross-sectional study conducted in two clinical units in Korea. PARTICIPANTS: Men (n = 86), premenopausal women (n = 94), and postmenopausal women (n = 357) participated in the study. MAIN OUTCOME MEASURES: We measured S1P levels and their relationships with bone mineral density, biochemical bone turnover markers, and uncoupling indices. RESULTS: S1P levels were significantly higher in the postmenopausal women than in the premenopausal women and men. High S1P concentrations were significantly associated with low bone mineral density values at some femur sites in the postmenopausal women (P = 0.015 to 0.049), at the lumbar spine in the premenopausal women (P = 0.017), and at all sites in men (P = 0.001 to 0.036) after adjustments with multiple covariates. S1P levels were positively correlated with bone resorption markers (P = 0.003 to 0.049), but not with formation markers in postmenopausal women. Higher S1P levels were associated with lower uncoupling indices (P = <0.001 to 0.048) in postmenopausal women. CONCLUSION: These findings suggest that S1P may primarily affect bone resorption, resulting in bone loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The alliance of sphingosine-1-phosphate and its receptors in immunity
Rivera, J., Proia, R. L., & Olivera, A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2400 · Cited by 616
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
Ishii, M., Egen, J. G., Klauschen, F., Meier-Schellersheim, M., Saeki, Y., Vacher, J., Proia, R. L., & Germain, R. N. (2009) · Nature · doi:10.1038/nature07713 · Cited by 515 · cited 2×
“From the viewpoint of its systemic effect, high plasma S1P levels induce S1PR2-mediated chemorepulsion of osteoclast precursors; therefore, S1P facilitates the entry of osteoclast precursors from blood vessels to bone parenchyma and promotes osteoclastogenesis (10, 11).”
Background
Cited by
Boning up on autophagy: The role of autophagy in skeletal biology
Shapiro, I. M., Layfield, R., Lotz, M., Settembre, C., & Whitehouse, C. (2014) · Autophagy · doi:10.4161/auto.26679 · Cited by 175
“Recently, a lysophospholipid-derived from sphingomyelin, sphingosine 1-phosphate (S1P), has been shown to be an osteoclast chemoattractant.23 Osteoclasts express S1PR (sphingosine-1-phosphate receptor), and by modulating the activity of mechanistic target of rapamycin (MTOR), S1P counteracts autophagy and promotes apo…”
BackgroundCoupling factors involved in preserving bone balance
Kim, B.-J., & Koh, J.-M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2981-y · Cited by 111
Self-citationSphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential
Meshcheryakova, A., Mechtcheriakova, D., & Pietschmann, P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1332180 · Cited by 74
Metadata
- Authors
- Lee, S. H., Lee, S.-Y., Lee, Y.-S., Kim, B.-J., Lim, K.-H., Cho, E.-H., Kim, S.-W., Koh, J.-M., & Kim, G. S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-08
- Volume
- 97
- Issue
- 8
- Pages
- E1421-E1428
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1993784402
- Cited by
- 60
- References
- 2
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Higher Circulating Sphingosine 1-Phosphate Levels Are Associated with Lower Bone Mineral Density and Higher Bone Resorption Marker in Humans. https://app.cochat.ai/papers/10.1210/jc.2012-1044
- The paper
- Lee, S. H., Lee, S.-Y., Lee, Y.-S., Kim, B.-J., Lim, K.-H., Cho, E.-H., Kim, S.-W., Koh, J.-M., & Kim, G. S. (2012). Higher Circulating Sphingosine 1-Phosphate Levels Are Associated with Lower Bone Mineral Density and Higher Bone Resorption Marker in Humans. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2012-1044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.